Danilova Yuliya Vasilyevna, Shagimardanova Elena Ilyasovna, Margulis Anna Borisovna, Toymentseva Anna Aleksandrovna, Balaban Nelly Pavlovna, Rudakova Nataliya Leonidovna, Rizvanov Albert Anatolyevich, Sharipova Margarita Rashidovna, Palotás András
Kazan Federal University, Kazan, Russia.
Kazan Federal University, Kazan, Russia.
Brain Res Bull. 2014 Sep;108:113-7. doi: 10.1016/j.brainresbull.2014.08.009. Epub 2014 Sep 26.
Aggregated β-amyloid peptides play key roles in the development of Alzheimer's disease, and recent evidence suggests that microbial particles, among others, can facilitate their polymerization. Bacterial enzymes, however, have been proved to be beneficial in degrading pathological fibrillar structures in clinical settings, such as strepto-kinases in resolving blood-clots. The purpose of this study was to investigate the ability of bacterial substances to effectively hydrolyze β-amyloid peptides. Degrading products of several proteinases from Bacillus pumilus were evaluated using MALDI-TOF mass-spectrometry, and their toxicity was assessed in vitro using cell-culture assays and morphological studies. These enzymes have proved to be non-toxic and were demonstrated to cleave through the functional domains of β-amyloid peptide. By yielding inactive fragments, proteinases of Bacillus pumilus may be used as candidate anti-amyloid agents.
聚集的β-淀粉样肽在阿尔茨海默病的发展中起关键作用,最近的证据表明,微生物颗粒等可促进其聚合。然而,已证明细菌酶在临床环境中有助于降解病理性纤维状结构,如链激酶用于溶解血凝块。本研究的目的是研究细菌物质有效水解β-淀粉样肽的能力。使用基质辅助激光解吸电离飞行时间质谱法评估了短小芽孢杆菌几种蛋白酶的降解产物,并使用细胞培养试验和形态学研究在体外评估了它们的毒性。这些酶已被证明无毒,并被证明可切割β-淀粉样肽的功能域。通过产生无活性片段,短小芽孢杆菌的蛋白酶可用作候选抗淀粉样蛋白药物。